[
    [
        {
            "time": "2023-10-01",
            "original_text": "Five Minutes With.... Cytiva CEO Emmanuel Ligner",
            "features": {
                "keywords": [
                    "Cytiva",
                    "CEO",
                    "Emmanuel Ligner"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Roche Most Innovative, Astra Zeneca Most Inventive",
            "features": {
                "keywords": [
                    "Roche",
                    "Astra Zeneca",
                    "innovative",
                    "inventive"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Eye disease startup to move to Mass. after Shire alum named CEO",
            "features": {
                "keywords": [
                    "eye disease",
                    "startup",
                    "Mass.",
                    "Shire",
                    "CEO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 3,
                "Time_Proximity": 2,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]